Closing the HRRm Testing Gap in Prostate Cancer Patients
Pfizer Global Medical Grants
UM Funding ID
FD03475
Sponsor
Pfizer Global Medical Grants
Category
International
Description
Seeks to enhance Homologous Recombination Repair gene mutation (HRRm) testing in Canadian prostate cancer patients.
Individual projects requesting up to a maximum of CAD $100,000 will be considered. The total available budget related to this RFP is $200,000 CAD.
VPRI Contact
Holly Musto
Research Contract CoordinatorHolly [dot] .Musto [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 23-Apr-2024 4:30 pm CST | 02-May-2024 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.